X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (95617) 95617
Newspaper Article (32504) 32504
Patent (5674) 5674
Magazine Article (878) 878
Book Chapter (494) 494
Dissertation (380) 380
Trade Publication Article (318) 318
Web Resource (260) 260
Book / eBook (178) 178
Publication (105) 105
Conference Proceeding (72) 72
Newsletter (58) 58
Book Review (57) 57
Report (18) 18
Government Document (14) 14
Journal / eJournal (12) 12
Reference (8) 8
Transcript (3) 3
Paper (2) 2
Streaming Video (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (75548) 75548
human papillomavirus (59988) 59988
female (48092) 48092
cervical cancer (35315) 35315
adult (26950) 26950
cancer (26018) 26018
middle aged (23110) 23110
oncology (22066) 22066
male (21882) 21882
vaccines (19556) 19556
immunization (15110) 15110
aged (14435) 14435
papillomavirus infections (12979) 12979
womens health (11902) 11902
adolescent (11550) 11550
risk factors (11249) 11249
research (10945) 10945
women (10726) 10726
animals (10388) 10388
health aspects (10291) 10291
papillomaviridae - genetics (9030) 9030
human-papillomavirus (8996) 8996
uterine cervical neoplasms - virology (8985) 8985
infections (8502) 8502
prevalence (8462) 8462
papillomavirus infections - virology (8460) 8460
papillomaviridae - isolation & purification (8381) 8381
young adult (8243) 8243
studies (8235) 8235
hpv (8156) 8156
immunology (8071) 8071
infection (7877) 7877
analysis (7493) 7493
microbiology (7251) 7251
dna (7036) 7036
infectious diseases (6920) 6920
pathology (6860) 6860
risk (6856) 6856
medical screening (6820) 6820
vaccination (6812) 6812
uterine cervical neoplasms - pathology (6807) 6807
medical research (6663) 6663
expression (6603) 6603
diagnosis (6586) 6586
polymerase chain reaction (6370) 6370
tumors (6364) 6364
squamous cell carcinoma (6319) 6319
virology (6282) 6282
papillomavirus infections - complications (6181) 6181
proteins (6019) 6019
obstetrics & gynecology (6008) 6008
squamous-cell carcinoma (5985) 5985
hygiene (5785) 5785
human necessities (5674) 5674
papillomavirus infections - epidemiology (5668) 5668
viruses (5664) 5664
medical or veterinary science (5632) 5632
prevention (5632) 5632
papillomavirus infections - prevention & control (5611) 5611
prognosis (5557) 5557
aged, 80 and over (5514) 5514
cell biology (5491) 5491
preparations for medical, dental, or toilet purposes (5475) 5475
epidemiology (5459) 5459
care and treatment (5357) 5357
research article (5261) 5261
carcinoma, squamous cell - pathology (5235) 5235
papillomavirus infections - diagnosis (5191) 5191
public health (5135) 5135
medicine (5071) 5071
dna, viral - analysis (5046) 5046
uterine cervical neoplasms - diagnosis (4974) 4974
public, environmental & occupational health (4936) 4936
uterine cervical neoplasms - prevention & control (4869) 4869
surgery (4867) 4867
deoxyribonucleic acid--dna (4860) 4860
mice (4825) 4825
carcinoma (4791) 4791
chemistry (4791) 4791
child (4749) 4749
medicine, research & experimental (4709) 4709
biochemistry (4680) 4680
cervical-cancer (4503) 4503
gene expression (4503) 4503
immunohistochemistry (4491) 4491
peptides (4454) 4454
metallurgy (4367) 4367
biochemistry & molecular biology (4355) 4355
genetic aspects (4323) 4323
retrospective studies (4261) 4261
apoptosis (4186) 4186
papillomaviruses (4015) 4015
carcinoma, squamous cell - virology (3998) 3998
medicine, general & internal (3990) 3990
organic chemistry (3970) 3970
cervical intraepithelial neoplasia (3939) 3939
cervix (3902) 3902
lesions (3849) 3849
vaginal smears (3776) 3776
head (3773) 3773
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (77) 77
Collection Dvlpm't (Acquisitions) - Vendor file (15) 15
Online Resources - Online (12) 12
UofT at Mississauga - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
St. Michael's Hospital - Stacks (4) 4
New College (Ivey) - Stacks (3) 3
UofT at Scarborough - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Reference (1) 1
Regis College - Stacks (1) 1
Robarts - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trinity College (John W Graham) - Reference (1) 1
UofT at Scarborough - Reference Desk (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (130699) 130699
French (2915) 2915
German (2032) 2032
Chinese (1165) 1165
Spanish (1028) 1028
Portuguese (476) 476
Japanese (464) 464
Russian (436) 436
Korean (354) 354
Polish (213) 213
Italian (177) 177
Danish (165) 165
Czech (107) 107
Swedish (89) 89
Dutch (85) 85
Hungarian (77) 77
Norwegian (77) 77
Turkish (60) 60
Finnish (55) 55
Bulgarian (43) 43
Croatian (32) 32
Ukrainian (32) 32
Slovenian (26) 26
Serbian (21) 21
Hebrew (20) 20
Slovak (18) 18
Persian (16) 16
Greek (13) 13
Icelandic (13) 13
Breton (12) 12
Lithuanian (11) 11
Romanian (11) 11
Estonian (7) 7
Bosnian (6) 6
Arabic (4) 4
Afrikaans (3) 3
Hindi (3) 3
Latvian (2) 2
Urdu (2) 2
Gaelic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9895, pp. 889 - 899
Summary Cervical cancer is caused by human papillomavirus infection. Most human papillomavirus infection is harmless and clears spontaneously but persistent infection with high-risk human papillomavirus (especially type 16... 
Internal Medicine | WOMEN | POPULATION | MEDICINE, GENERAL & INTERNAL | PERSISTENCE | DNA | VACCINE | HPV INFECTION | FOLLOW-UP | RISK | CYTOLOGY | INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Human papillomavirus 11 - ultrastructure | Uterine Cervical Neoplasms - pathology | Human papillomavirus 16 - immunology | Human papillomavirus 6 - ultrastructure | Papillomavirus Infections - pathology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Human papillomavirus 11 - immunology | Human papillomavirus 16 - ultrastructure | Human papillomavirus 11 - pathogenicity | Papillomavirus Vaccines - administration & dosage | Human papillomavirus 6 - pathogenicity | Human papillomavirus 16 - pathogenicity | Cross-Sectional Studies | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaginal Smears | Mass Screening | Virus Replication | Human papillomavirus 18 - pathogenicity | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Human papillomavirus 18 - ultrastructure | Papillomavirus Vaccines - immunology | Developing Countries | Cell Transformation, Neoplastic - pathology | Cell Transformation, Viral | Prevention | Papillomaviruses | Usage | Vaccines | Properties | Papillomavirus infections | Risk factors | Cervical cancer | Studies | Human papillomavirus | Immunization | Cellular biology | Womens health | Medical screening | Epidemiology | Age
Journal Article
Virology, ISSN 0042-6822, 2016, Volume 500, pp. 218 - 225
Abstract Human Papillomavirus E6 and E7 play critical roles in cancer development, although not all isolates of the viral oncoproteins are identical... 
Infectious Disease | pRb | CKII phosphorylation | TBP | HPV | ONCOPROTEIN | PROTEIN | HUMAN-PAPILLOMAVIRUS TYPE-16 | SEQUENCE VARIATION | PHOSPHORYLATION | RETINOBLASTOMA TUMOR-SUPPRESSOR | 16 E6 | E7 | COMPLEX-FORMATION | VIROLOGY | ADENOVIRUS E1A | DEGRADATION | Phosphorylation | Human papillomavirus 16 - physiology | Humans | Retinoblastoma Protein - metabolism | Amino Acid Motifs | Papillomavirus E7 Proteins - genetics | Papillomavirus Infections - genetics | TATA-Box Binding Protein - metabolism | Papillomavirus E7 Proteins - metabolism | TATA-Box Binding Protein - genetics | Papillomavirus Infections - metabolism | Retinoblastoma Protein - genetics | Protein Binding | Papillomavirus E7 Proteins - chemistry | Papillomavirus Infections - virology | Human papillomavirus 16 - chemistry | Binding Sites | Human papillomavirus 16 - genetics | Cell Transformation, Viral | Papillomavirus infections | Human papillomavirus 16/physiology | Papillomavirus Infections/virology | Papillomavirus Infections/metabolism | Papillomavirus E7 Proteins/metabolism | TATA-Box Binding Protein/metabolism | Retinoblastoma Protein/genetics | Virology | Life Sciences | Microbiology and Parasitology | Human health and pathology | TATA-Box Binding Protein/genetics | Papillomavirus E7 Proteins/chemistry | Human papillomavirus 16/chemistry | Papillomavirus E7 Proteins/genetics | Human papillomavirus 16/genetics | Retinoblastoma Protein/metabolism | Papillomavirus Infections/genetics | Cancer
Journal Article
Virus research, ISSN 0168-1702, 2017, Volume 231, pp. 108 - 118
•Preclinical animal papillomavirus (PV) models have established key foundational observations on HPV biology, viral gene function and host-virus interactions... 
Codon-modified viral genes | in vivo PV viral function | Innate immune responses to PV infections | Animal papillomavirus models | Vaccine and immunotherapeutics for PV infections | CPV | BPV | CRPV | MmuPV1 | OPEN READING FRAME | BOVINE PAPILLOMAVIRUS | Vaccine and immunotherapeutics for PV | COTTONTAIL RABBIT PAPILLOMAVIRUS | ORAL PAPILLOMAVIRUS | MHC CLASS-I | VIROLOGY | VIRAL-DNA | MOUSE MICROMYS-MINUTUS | infections | SQUAMOUS-CELL CARCINOMA | VIRUS-LIKE PARTICLES | DNA VACCINATION | Cottontail rabbit papillomavirus - genetics | Lambdapapillomavirus - genetics | Lambdapapillomavirus - growth & development | Bovine papillomavirus 1 - pathogenicity | Humans | Papillomavirus Vaccines - biosynthesis | Uterine Cervical Neoplasms - pathology | Cottontail rabbit papillomavirus - growth & development | Papillomaviridae - genetics | Bovine papillomavirus 1 - genetics | Papillomavirus Infections - pathology | Papillomaviridae - immunology | Skin Neoplasms - prevention & control | Cattle | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Cottontail rabbit papillomavirus - immunology | Papillomavirus Vaccines - administration & dosage | Disease Models, Animal | Skin Neoplasms - pathology | Rabbits | Papillomaviridae - growth & development | Cottontail rabbit papillomavirus - pathogenicity | Skin Neoplasms - immunology | Uterine Cervical Neoplasms - prevention & control | Rats | Uterine Cervical Neoplasms - immunology | Lambdapapillomavirus - immunology | Primates - virology | Papillomaviridae - pathogenicity | Animals | Bovine papillomavirus 1 - growth & development | Papillomavirus Infections - prevention & control | Skin Neoplasms - virology | Dogs | Uterine Cervical Neoplasms - virology | Bovine papillomavirus 1 - immunology | Mice | Lambdapapillomavirus - pathogenicity | Medical colleges | Health aspects | Papillomavirus infections | Immunotherapy | Analysis | Medical research | AIDS vaccines | Codon | Viral proteins | Primates | Medicine, Experimental
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10008, pp. 2078 - 2088
...Introduction In 2008, one in six new cancer diagnoses worldwide was attributable to an infectious pathogen. Human papillomavirus (HPV) causes one-third... 
Internal Medicine | REGRESSION | MEDICINE, GENERAL & INTERNAL | ELECTROPORATION | METHYLATION | INTEGRATION | IMMUNOTHERAPY | E2 BINDING-SITES | NATURAL-HISTORY | CANCER | BURDEN | EXPRESSION | Human papillomavirus 18 - immunology | Humans | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Cervical Intraepithelial Neoplasia - drug therapy | Human papillomavirus 16 - immunology | Papillomavirus E7 Proteins - genetics | Young Adult | Cancer Vaccines - therapeutic use | Adult | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | DNA-Binding Proteins - immunology | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Repressor Proteins - genetics | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Vaccines, DNA - therapeutic use | DNA-Binding Proteins - genetics | Cervical Intraepithelial Neoplasia - virology | Cancer Vaccines - immunology | Repressor Proteins - immunology | Papillomavirus Infections - drug therapy | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Human papillomavirus 16 - genetics | Proteins | Cervix dysplasia | DNA | Clinical trials | Product development | Vaccines | Health aspects | Papillomavirus infections | Medical research | Analysis | Medicine, Experimental | Human papillomavirus | Immunization | Womens health | Immunotherapy | Genomes | Cervical cancer | Deoxyribonucleic acid--DNA
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 361, Issue 19, pp. 1838 - 1847
Journal Article